一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权合力打造医学影像AI核心壁垒

智通财经04-27

智通财经APP讯，一脉阳光(02522)发布公告，于2026年4月26日，公司、买方一脉阳光医学影像(香港)有限公司、卖方1 Sun Seeds Management Co., Limited及目标公司1 Hong Kong Sun Seeds Management Co., Limited订立购股协议1，据此，买方拟购买标的股本1(目标公司1的100%股权)，总代价为1.85亿港元;公司、买方、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2630733403?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-27 07:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2630733403","market":"fut","top_or_hot":-1,"title":"一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权 合力打造医学影像AI核心壁垒","media":"智通财经","content":"<div>\n<p>智通财经APP讯，一脉阳光(02522)发布公告，于2026年4月26日，公司、买方一脉阳光医学影像(香港)有限公司、卖方1 Sun Seeds Management Co., Limited及目标公司1 Hong Kong Sun Seeds Management Co., Limited订立购股协议1，据此，买方拟购买标的股本1(目标公司1的100%股权)，总代价为1.85亿港元;公司、买方、...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1434111.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权 合力打造医学影像AI核心壁垒</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权 合力打造医学影像AI核心壁垒\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-27 07:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1434111.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，一脉阳光(02522)发布公告，于2026年4月26日，公司、买方一脉阳光医学影像(香港)有限公司、卖方1 Sun Seeds Management Co., Limited及目标公司1 Hong Kong Sun Seeds Management Co., Limited订立购股协议1，据此，买方拟购买标的股本1(目标公司1的100%股权)，总代价为1.85亿港元;公司、买方、...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1434111.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AIPO","symbol_name":"Defiance AI and Power Infrastructure ETF","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1434111.html","article_id":"2630733403","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2630733403","pubTimestamp":1777246301,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"截至本公告日期，目标公司2并无实际业务运营，目标公司2的唯一资产为持有的影禾医脉8.0000%股权。本次进一步增持影禾医脉股权，充分体现集团对影禾医脉未来长远发展的充足信心，并与一脉阳光数智影像+ 的整体转型升级发展需求形成高度战略契合。双方将依托各自核心优势深度协同、共生共荣，打造行业难以复制的医学影像AI核心壁垒。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AIPO":"Defiance AI and Power Infrastructure ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","02251":"鹰瞳科技-B","BK1219":"保健护理服务","ARTY":"ISHARES FUTURE AI & TECH ETF","BK1189":"医疗保健技术","02522":"一脉阳光","AGIX":"通用人工智能 ETF-AGIX"},"translate_title":"Yimai Sunshine (02522) plans to add approximately HK$353 million to further increase its stake in Yinghe Medical Pulse to jointly build the core barrier of medical imaging AI","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02251":1.5,"CHAT":1.5,"AGIX":1.5,"02522":1.5,"AIPO":1.5,"ARTY":1.5},"content_text":"智通财经APP讯，一脉阳光(02522)发布公告，于2026年4月26日，公司、买方一脉阳光医学影像(香港)有限公司、卖方1 Sun Seeds Management Co., Limited及目标公司1 Hong Kong Sun Seeds Management Co., Limited订立购股协议1，据此，买方拟购买标的股本1(目标公司1的100%股权)，总代价为1.85亿港元;公司、买方、卖方2永安价值4号有限合伙基金及目标公司2 Wingon Medical Technology Co., Limited永安医疗科技有限公司订立购股协议2，据此，买方拟购买标的股本2(目标公司2的100%股权)，总代价为1.68亿港元。代价将透过公司向卖方支付代价股份的方式偿付。根据购股协议1，于完成后，集团将于目标公司1的100%股权中拥有权益，目标公司1将成为公司的间接全资附属公司，目标公司1的财务业绩将于集团账目内综合入账。截至本公告日期，目标公司1并无实际业务运营，目标公司1的唯一资产为持有的影禾医脉8.8275%股权。根据购股协议2，于完成后，集团将于目标公司2的100%股权中拥有权益，目标公司2将成为公司的间接全资附属公司，目标公司2的财务业绩将于集团账目内综合入账。截至本公告日期，目标公司2并无实际业务运营，目标公司2的唯一资产为持有的影禾医脉8.0000%股权。本次收购事项是集团由项目孵化迈向战略重仓的关键跃升，亦是完善“数据模型-场景”三位一体战略布局、牢牢夯实AI技术底层能力的核心举措，为一脉阳光实现全球数智影像+ 生态布局及战略价值升级的关键动作，完全契合集团长期深耕医学影像领域的发展规划。本次进一步增持影禾医脉股权，充分体现集团对影禾医脉未来长远发展的充足信心，并与一脉阳光数智影像+ 的整体转型升级发展需求形成高度战略契合。依托资本纽带深化合作，双方升级共生发展模式：集团凭借全国影像中心营运优势，沉淀海量高品质临床数据与应用场景;影禾医脉以前沿技术创新为核心引擎，持续迭代大模型与AI智慧体能力，形成数据驱动技术、技术赋能场景的双向循环闭环，构建可持续的协同发展体系。双方将依托各自核心优势深度协同、共生共荣，打造行业难以复制的医学影像AI核心壁垒。于战略层面，本次收购事项将为集团带来多元价值提升：产业链维度，依托影禾医脉顶尖AI技术优势，补全技术短板、完善业务布局，加速向数据驱动型智慧医疗服务升级，强化核心竞争力;服务维度，透过前沿AI技术落地，有效提升各影像中心及合作医疗机构的诊断精准度与营运效率，更好满足临床诊疗需求;行业布局维度，助力集团抢抓影像AI赛道发展机遇，巩固先发优势，驱动业务稳健增长，稳固集团于国内医学影像AI行业的领先地位。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2630733403","isCrawlerRequest":true}

一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权 合力打造医学影像AI核心壁垒

精彩评论

一脉阳光(02522)拟合共约3.53亿港元进一步增持影禾医脉股权合力打造医学影像AI核心壁垒